Sanofi US Independent Medical Education Grants 4th Quarter 2011

Sanofi US – Independent Medical Education Grants 4th Quarter 2011 Sanofi-aventis U.S. Inc (“Sanofi US”), A SANOFI COMPANY, is committed to supporting ...
3 downloads 0 Views 278KB Size
Sanofi US – Independent Medical Education Grants 4th Quarter 2011 Sanofi-aventis U.S. Inc (“Sanofi US”), A SANOFI COMPANY, is committed to supporting independent medical education activities for patients, consumers and healthcare professionals in our areas of therapeutic interest that have the potential to improve patient care and health outcomes.

Recipient Name(s) 1 Alaska Pharmacists Association American Academy of Family Physicians MedEd Architects LLC American Academy of Physician Assistants Medical Logix, LLC American Association of Diabetes Educators Diabetes Association of Atlanta, Inc. American College of Cardiology Foundation Med-IQ, LLC American Diabetes Association American Diabetes Association American Diabetes Association

Activity Title

Funding Amount2

Differentiating Type 1, 1.5 and 2 Diabetes AAFPLearningLink.org - Newer Treatment Options in Diabetes Mellitus

$2,000.00 $349,824.00

State of the Art Diabetes Management - Overcoming Barriers in the Use of Early Insulin Therapy

$61,440.00

18th Annual Diabetes University Innovations in Translation - Atrial Fibrillation - A Clinical Focus Session at ACC.12

$5,000.00 $100,000.00

13th Annual American Diabetes Association Community Forum 9th Annual Professional Education Symposium, 2011 - Diabetes Below the Belt Line Health Care Quality & Education in Diabetes Management - Overcoming Clinical Inertia to Achieve Glycemic Goals

$5,000.00 $5,000.00 $359,750.00

American Diabetes Association

Diabetes & The Brain - A Research Symposium

$5,000.00

American Health Resources, Inc.

A Comprehensive Management Approach in Treating Atrial Fibrillation

$4,500.00

American Pharmacists Association

Pharmaceutical Care for Patients with Diabetes - APhA Certificate Training Program National Offerings (Practice Based)

$76,280.00

1

Grant applicant names are provided by the grant requestor. If applicants apply as a group for a single educational activity, up to two applicants are identified above. 2

“Funding Amount” is the amount that sanofi-aventis U.S. funded during the quarter identified above based upon a grant agreement. Grant recipients are required to return any unused funds. Information on educational grant funds returned on an individual activity basis is not reported. This quarter’s total of returned unused funds is $215,276.57. “Funding Amount” does not include funds that may have been provided by other affiliated Sanofi Company Entities, (e.g., Sanofi Pasteur, Genzyme Corporation). 3

Collaboration (Shared) Funding – is the full amount of a grant funded under an agreement with Regeneron, some or all of which may be shared between the collaborating entities.

Sanofi US, A SANOFI COMPANY

Sanofi US – Independent Medical Education Grants 4th Quarter 2011 Recipient Name(s) 1 American Pharmacists Association American Society of Consultant Pharmacists Annenberg Center for Health Sciences at Eisenhower Clinical Care Options, LLC Aultman Hospital Boston University, BUMC Cine-Med American Society of Cosmetic Dermatology & Aesthetic Surgery Cine-Med American Society of Cosmetic Dermatology & Aesthetic Surgery Cleveland Clinic Educational Foundation Cook Children’s Medical Center Emory University Excel Continuing Education

Activity Title

Funding Amount2

APhA2012 Continuing Pharmacy Education Session - Join the Team to Tackle the Complications and Comorbidities of Diabetes Optimizing Care for Long-Term Care Residents With Diabetes - The Role of Insulin Analogs

$11,000.00 $4,000.00

CCO Independent Conference Coverage of the 2012 Gastrointestinal Cancers Symposium

$15,000.00 Collaboration

The Eleventh Annual Cancer Conference focusing on updates on gastrointestinal tumors, new developments in genitourinary oncology, hot topics in oncology and what’s new in breast cancer Individualizing Diabetes Care at the Bedside - State of the Art Nursing in Inpatient Diabetes

3

$5,000.00 Collaboration

3

$10,000.00 $15,000.00

The Art and Science of Cosmetic Rejuvenation

Demonstration Product Provided

ASCDAS 2011 Annual Meeting, Exhibition and Workshops

Demonstration Product Provided

$15,000.00

Shaping the Future of Cardiovascular Care - Progress and Controversies 2012 Pediatric Endocrine Society of Texas, Oklahoma, Louisiana, and Arkansas Conference 2nd Annual State of the Art Multidisciplinary Treatment of Gastrointestinal Cancers 2nd Annual Hematology Oncology Symposium of Puerto Rico - Translating Today’s Science into Tomorrow’s Practice

$2,500.00 $4,000.00 $2,500.00 Collaboration

$5,000.00 Collaboration

1

Grant applicant names are provided by the grant requestor. If applicants apply as a group for a single educational activity, up to two applicants are identified above. 2

“Funding Amount” is the amount that sanofi-aventis U.S. funded during the quarter identified above based upon a grant agreement. Grant recipients are required to return any unused funds. Information on educational grant funds returned on an individual activity basis is not reported. This quarter’s total of returned unused funds is $215,276.57. “Funding Amount” does not include funds that may have been provided by other affiliated Sanofi Company Entities, (e.g., Sanofi Pasteur, Genzyme Corporation). 3

Collaboration (Shared) Funding – is the full amount of a grant funded under an agreement with Regeneron, some or all of which may be shared between the collaborating entities.

Sanofi US, A SANOFI COMPANY

3

3

Sanofi US – Independent Medical Education Grants 4th Quarter 2011 Recipient Name(s) 1

Activity Title

Funding Amount2 $15,000.00

Florida Medical Association Florida Society of Dermatologic Surgeons

Advances in Dermatologic Surgery

Greater Northwest Ohio Diabetes Association

2011 Greater Northwest Ohio Association Diabetes Symposium

$5,000.00

Illinois Academy of Family Physicians

Update on Practice Innovation CME - Group Diabetes Visits - Presentation at the Illinois Academy of Family Physicians Annual Meeting

$3,000.00

Imedex, LLC

Great Debates and Updates in Gastrointestinal Malignancies

Joan and Sanford I Weill Medical College of Cornell University

Annual Update on Gastrointestinal Cancers - A Multidisciplinary Approach to Screening, Diagnosis, and Treatment

Joslin Diabetes Center, Inc.

Critical Literature Analysis 2011 - Applying the Data to Clinical Management

Joslin Diabetes Center, Inc. President and Fellows of Harvard College acting through the Harvard Medical School

Joslin Diabetes Center and Harvard Medical School - Advances in Diabetes 2011

Kansas University Endowment Association

The University of Kansas Multidisciplinary Cancer Symposium

Med-IQ, LLC

Optimal Strategies for Early and Ongoing Treatment of Multiple Sclerosis

$327,759.00

Med-IQ, LLC

Expert Perspectives and Emerging Data - Avoiding the Dangers of Cancer Related Thrombosis

$110,953.10

Med-IQ, LLC American Association of Diabetes Educators

Finding Common Ground in the Use of Insulin Pens

$458,382.50

Demonstration Product Provided

$20,000.00 Collaboration

$5,000.00 Collaboration

$15,000.00 $5,000.00 Collaboration

Grant applicant names are provided by the grant requestor. If applicants apply as a group for a single educational activity, up to two applicants are identified above. “Funding Amount” is the amount that sanofi-aventis U.S. funded during the quarter identified above based upon a grant agreement. Grant recipients are required to return any unused funds. Information on educational grant funds returned on an individual activity basis is not reported. This quarter’s total of returned unused funds is $215,276.57. “Funding Amount” does not include funds that may have been provided by other affiliated Sanofi Company Entities, (e.g., Sanofi Pasteur, Genzyme Corporation). 3

Collaboration (Shared) Funding – is the full amount of a grant funded under an agreement with Regeneron, some or all of which may be shared between the collaborating entities.

Sanofi US, A SANOFI COMPANY

3

$500,000.00

1

2

3

3

Sanofi US – Independent Medical Education Grants 4th Quarter 2011 Recipient Name(s) 1

Activity Title

Medical Education Resources Carden Jennings Publishing Company, Ltd.

22nd International Prostate Cancer Update

Medical Education Resources Cosmetic Bootcamp, LLC

Cosmetic Bootcamp University 2011

Medscape LLC

Emerging Approaches to Targeting VEGF

Mount Sinai School of Medicine (MSSM) Mount Sinai School of Medicine (MSSM) Mount Sinai School of Medicine (MSSM) MPD Foundation

Funding Amount2 $42,562.00 $34,000.00 Demonstration Product Provided

$50,000.00 Collaboration

Chemotherapy Foundation Symposium, Innovative Cancer Therapy for Tomorrow 6th Annual Mid-Atlantic Hospital Medicine Symposium - Mastering the Care of the Hospitalized Patient 2011 Patient Symposium - Changing the Future - New Trends in Multiple Sclerosis Research and Treatment New York City Myeloproliferative Neoplasm (MPN) Patient Education Symposium

National Association for Continuing Education Physicians Continuing Education

The New Face of Fillers - An Evidence Based, Multi-Specialty CME Supplement, Part I and Part II

National Council of Asian Pacific Islander Physicians

Diabetes in Asian Americans, Native Hawaiians, and Pacific Islanders - A Call to Action

New Jersey Society of Physician Assistants

Type 2 Diabetes - Treatment with Oral - Insulin Therapies

New York Medical College Office of Continuing Medical Education Contemporary Forums

The Seventh Annual Oncology Congress Advancing Quality in Cancer Care 2011

$75,000.00 Collaboration

$25,000.00 $7,500.00 $25,000.00 Demonstration Product Provided

$20,000.00 $3,000.00 $10,000.00 Collaboration

Grant applicant names are provided by the grant requestor. If applicants apply as a group for a single educational activity, up to two applicants are identified above. “Funding Amount” is the amount that sanofi-aventis U.S. funded during the quarter identified above based upon a grant agreement. Grant recipients are required to return any unused funds. Information on educational grant funds returned on an individual activity basis is not reported. This quarter’s total of returned unused funds is $215,276.57. “Funding Amount” does not include funds that may have been provided by other affiliated Sanofi Company Entities, (e.g., Sanofi Pasteur, Genzyme Corporation). 3

Collaboration (Shared) Funding – is the full amount of a grant funded under an agreement with Regeneron, some or all of which may be shared between the collaborating entities.

Sanofi US, A SANOFI COMPANY

3

$4,000.00

1

2

3

3

Sanofi US – Independent Medical Education Grants 4th Quarter 2011 Recipient Name(s) 1

Activity Title

North Carolina Academy of Family Physicians

2011 Winter Family Physicians Weekend - Diabetes

Nurse Practitioner Healthcare Foundation

Managing Your Diabetes - A Personal Guide to Better Health

Oregon Health & Science University Foundation Penn State University PeerView Institute for Medical Education, Inc. Postgraduate Institute for Medicine Clinical Care Options, LLC Postgraduate Institute for Medicine Medtelligence, LLC

$4,000.00 $80,000.00

Fourth Annual Pacific Northwest Diabetes Summit PeerView in Session, What’s New in Multiple Sclerosis Therapeutics - A Clinical Update from Amsterdam

$5,000.00 $125,000.00

CCO Independent Conference Coverage of the 2011 Combined Meeting of the Connective Tissue Oncology Society and the Musculoskeletal Tumor Society October 26-29, 2011 - Chicago, Illinois

$95,000.00

Principal Investigators Spotlight - Comparing Recent Large-Scale Trials in Atrial Fibrillation - You Be The Judge

$67,166.00

Pri-Med Institute Horizon CME, Inc

Evidence Based Strategies to Improve Glycemic Control in Type 2 Diabetes

prIME Oncology

prIME Cases - Colorectal Cancer 2011

prIME Oncology

Evaluating Emerging Targeted Therapies in the Management of Metastatic Colorectal Cancer

Prostate Cancer Foundation

18th Annual Prostate Cancer Foundation Scientific Retreat

Research To Practice

What Clinicians Want to Know - Addressing the Most Common Questions and Controversies in the Current Clinical Management of Gastrointestinal Cancers – Independent Satellite Symposium (ISS) Held as an Ancillary Event During the 2012 Gastrointestinal Cancers Symposium

1

Funding Amount2

$912,125.00 $10,000.00 3 Collaboration $190,745.00 3 Collaboration $300,000.00 $50,000.00 3 Collaboration

Grant applicant names are provided by the grant requestor. If applicants apply as a group for a single educational activity, up to two applicants are identified above. 2

“Funding Amount” is the amount that sanofi-aventis U.S. funded during the quarter identified above based upon a grant agreement. Grant recipients are required to return any unused funds. Information on educational grant funds returned on an individual activity basis is not reported. This quarter’s total of returned unused funds is $215,276.57. “Funding Amount” does not include funds that may have been provided by other affiliated Sanofi Company Entities, (e.g., Sanofi Pasteur, Genzyme Corporation). 3

Collaboration (Shared) Funding – is the full amount of a grant funded under an agreement with Regeneron, some or all of which may be shared between the collaborating entities.

Sanofi US, A SANOFI COMPANY

Sanofi US – Independent Medical Education Grants 4th Quarter 2011 Recipient Name(s) 1

Activity Title

Funding Amount2

Research To Practice

5-Minute Journal Club A Weekly Review of Key Presentations and Posters from the 2011 American Society of Hematology (ASH) Annual Meeting

$75,000.00

Research To Practice

Cancer Conference Update - An Enduring Audio, Web and Mobile Review of Key Presentations and Posters from the 53rd American Society of Hematology Annual Meeting

$65,000.00

Rush University Medical Center

Diabetes Support and Education in a Patient Centered Medical Home

$60,000.00

Texas Heart Institute The Angiogenesis Foundation

Second Annual Diabetes and Endocrinology Research Center (DERC) Symposium - Diabetes and Its Complications - An Update for the Primary Care Physician The 9th International M. Judah Folkman Conference Angiogenesis - New Frontiers in Therapeutic Development

$5,000.00 $25,000.00 Collaboration

3

The Heart Rhythm Society

Atrial Fibrillation for Allied Professionals

$2,500.00

The Institute for Wellness and Education Insight Therapeutics, LLC

Overcoming the Barriers to Starting Insulin

$5,000.00

The Leukemia & Lymphoma Society

Emerging Therapies for Blood Cancer Patients

The Ohio State University

3rd Annual Contemporary Multi-Disciplinary Cardiovascular Medicine

$5,000.00

The University of Texas

Diabetes Disease State Management Online Course & Workshop

$5,000.00

The University of Texas Southwestern Medical Center at Dallas

Diabetes Management - Primary and Secondary Prevention Strategies

$5,000.00

$10,000.00

1

Grant applicant names are provided by the grant requestor. If applicants apply as a group for a single educational activity, up to two applicants are identified above. 2

“Funding Amount” is the amount that sanofi-aventis U.S. funded during the quarter identified above based upon a grant agreement. Grant recipients are required to return any unused funds. Information on educational grant funds returned on an individual activity basis is not reported. This quarter’s total of returned unused funds is $215,276.57. “Funding Amount” does not include funds that may have been provided by other affiliated Sanofi Company Entities, (e.g., Sanofi Pasteur, Genzyme Corporation). 3

Collaboration (Shared) Funding – is the full amount of a grant funded under an agreement with Regeneron, some or all of which may be shared between the collaborating entities.

Sanofi US, A SANOFI COMPANY

Sanofi US – Independent Medical Education Grants 4th Quarter 2011 Recipient Name(s) 1

Activity Title

Funding Amount2

Trustees of Purdue University PeerView Institute for Medical Education, Inc.

PeerView Live, Taking Stock of Recent Clinical Research in Multiple Sclerosis What is the Potential Impact of Emerging Therapies on Treatment Selection?

$336,410.00

University of Southern California

XIII Curso Intensivo de Diabetes, Endocrinologia y Enfermedades Metabolicas

$5,000.00

University of Texas Health Science Center at San Antonio

2011 CTRC-AACR (Cancer Therapy& Research – American Association for Cancer Research) San Antonio Breast Cancer Symposium

University of Vermont and State Agricultural College

Eastern Winter Dermatology 2012

University of Virginia Discovery Communications, LLC

Targeting Postprandial Glucose in Patients with Type 2 Diabetes - Why, When, and How

VHS Detroit Receiving Hospital, Inc.

5th Annual Diabetes Symposium

$5,000.00

Virginia Academy of Family Physicians

2012 VAFP Winter Family Medicine Weekend - What should you really know about type 2 diabetes? When almost everything you think you know isn’t so!

$2,500.00

Wake Forest University Health Sciences

14th Annual Diabetes Management Conference

$5,000.00

Washington University Kilo Diabetes & Vascular Research Foundation

Current Topics in Diabetes, Endocrinology and Vascular Disease

$3,000.00

Wayne State University

Performance Improvement CME (PICME) for the Southeast Michigan Beacon Project

$50,000.00 $5,000.00 Demonstration Product Provided

$99,920.00

$10,000.00

1

Grant applicant names are provided by the grant requestor. If applicants apply as a group for a single educational activity, up to two applicants are identified above. 2

“Funding Amount” is the amount that sanofi-aventis U.S. funded during the quarter identified above based upon a grant agreement. Grant recipients are required to return any unused funds. Information on educational grant funds returned on an individual activity basis is not reported. This quarter’s total of returned unused funds is $215,276.57. “Funding Amount” does not include funds that may have been provided by other affiliated Sanofi Company Entities, (e.g., Sanofi Pasteur, Genzyme Corporation). 3

Collaboration (Shared) Funding – is the full amount of a grant funded under an agreement with Regeneron, some or all of which may be shared between the collaborating entities.

Sanofi US, A SANOFI COMPANY